Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05932862
Title First-in Human Phase I Study of ISM3091 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors InSilico Medicine Hong Kong Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Exelixis Clinical Site 12 RECRUITING Fountain Valley California 92708 United States Details
Exelixis Clinical Site 8 RECRUITING Orlando Florida 32827 United States Details
Exelixis Clinical Site 10 RECRUITING Kansas City Missouri 64111 United States Details
Exelixis Clinical Site 9 RECRUITING New Brunswick New Jersey 08901 United States Details
Exelixis Clinical Site 5 RECRUITING New York New York 10029 United States Details
Exelixis Clinical Site 7 RECRUITING Cleveland Ohio 44106 United States Details
Exelixis Clinical Site 11 RECRUITING Germantown Tennessee 38138 United States Details
Exelixis Clinical Site 6 RECRUITING Nashville Tennessee 37203 United States Details
Exelixis Clinical Site 4 RECRUITING Austin Texas 78758 United States Details
Exelixis Clinical Site 1 RECRUITING Houston Texas 77030 United States Details
Exelixis Clinical Site 2 WITHDRAWN Houston Texas 77030 United States Details
Exelixis Clinical Site 3 RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field